aTYR PHARMA (ATYR) Research & Development (2014 - 2026)
aTYR PHARMA (ATYR) posted Research & Development of $6.75 million for Q2 2026, down 56.1% from $15.38 million a year earlier and down 7.8% from the prior quarter.
Powered by 
Analysis
aTYR PHARMA (ATYR) Research & Development (2014 - 2026) Analysis & Trends
For the trailing twelve months through Jun 30, 2026, Research & Development at aTYR PHARMA was $47.09 million, down 13.2% year-over-year; for FY2025, it was $60.22 million, up 10.8% from FY2024.
- Annual Research & Development shows a five-year compound annual growth rate of 28.3% (FY2020 to FY2025).
- In prior years, aTYR PHARMA's Research & Development was $54.37 million in FY2024 (+28.6%), $42.29 million in FY2023 (-1.2%), $42.81 million in FY2022 (+84.0%) and $23.26 million in FY2021 (+34.5%).
- The Q2 2026 figure stands as the lowest quarterly Research & Development since Q4 2021.
- On a year-over-year basis, Research & Development has declined in each of the last three quarters, with an average decline of 2.2% over the last eight quarters.
- The strongest year-over-year quarter for Research & Development in the past five years was Q4 2022, with growth of 150.4%; the weakest was Q2 2026, with a decline of 56.1%.
- According to Business Quant data, Research & Development for the three prior quarters was $7.32 million (Q1 2026), $10.89 million (Q4 2025) and $22.13 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,136.97 Bn | 1,105.55 Bn | 19.71 Bn | 3.82 Bn |
| 2 | Johnson & Johnson | 619.72 Bn | 538.25 Bn | 17.26 Bn | 3.65 Bn |
| 3 | AbbVie | 503.40 Bn | 476.52 Bn | 12.70 Bn | 2.34 Bn |
| 4 | Merck | 370.15 Bn | 324.53 Bn | 12.21 Bn | 9.74 Bn |
| 5 | Novartis Ag | 298.64 Bn | 262.63 Bn | 11.24 Bn | 2.85 Bn |
| 6 | Astrazeneca | 261.07 Bn | 234.76 Bn | 12.86 Bn | 4.05 Bn |
| 7 | Amgen | 237.00 Bn | 192.40 Bn | 7.24 Bn | 1.87 Bn |
| 8 | Gilead Sciences | 191.24 Bn | 165.43 Bn | 6.22 Bn | 1.76 Bn |
| 9 | Pfizer | 170.31 Bn | 116.96 Bn | 10.94 Bn | 2.81 Bn |
| 10 | aTYR PHARMA | 16.81 Mn | -276.01 Mn | - | 6.75 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 6.75 Mn |
| Mar 31, 2026 | 7.32 Mn |
| Dec 31, 2025 | 10.89 Mn |
| Sep 30, 2025 | 22.13 Mn |
| Jun 30, 2025 | 15.38 Mn |
| Mar 31, 2025 | 11.81 Mn |
| Dec 31, 2024 | 12.23 Mn |
| Sep 30, 2024 | 14.81 Mn |
| Jun 30, 2024 | 13.97 Mn |
| Mar 31, 2024 | 13.36 Mn |
| Dec 31, 2023 | 12.76 Mn |
| Sep 30, 2023 | 10.32 Mn |
| Jun 30, 2023 | 9.84 Mn |
| Mar 31, 2023 | 9.38 Mn |
| Dec 31, 2022 | 14.91 Mn |
| Sep 30, 2022 | 9.87 Mn |
| Jun 30, 2022 | 9.14 Mn |
| Mar 31, 2022 | 8.90 Mn |
| Dec 31, 2021 | 5.96 Mn |
| Sep 30, 2021 | 5.14 Mn |
API Access
aTYR PHARMA Research & Development API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=research-and-development&ticker=ATYR&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "research-and-development", "ticker": "ATYR", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=research-and-development&ticker=ATYR&period=max&api_key=YOUR_API_KEY");
const data = await res.json();